12:00 AM
 | 
Jul 09, 2012
 |  BC Week In Review  |  Company News  |  Other News

GeneAssess cancer news

GeneAssess received a commitment for up to $500,000 in pre-seed funding from not-for-profit Foundation Venture Capital Group (FVCG). The newco, which was spun...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >